Cargando…
Targeting CD38 in Neoplasms and Non-Cancer Diseases
SIMPLE SUMMARY: CD38 remains an interesting target for anticancer therapy. Its relatively high abundance in neoplasms and crucial impact on NAD+/cADPR metabolism and the activity of T cells allows for changing the immune response in autoimmune diseases, neoplasms, and finally the induction of cell d...
Autores principales: | Szlasa, Wojciech, Czarny, Jakub, Sauer, Natalia, Rakoczy, Katarzyna, Szymańska, Natalia, Stecko, Jakub, Kołodziej, Maksymilian, Kaźmierczak, Maciej, Barg, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454480/ https://www.ncbi.nlm.nih.gov/pubmed/36077708 http://dx.doi.org/10.3390/cancers14174169 |
Ejemplares similares
-
Application of Luteolin in Neoplasms and Nonneoplastic Diseases
por: Rakoczy, Katarzyna, et al.
Publicado: (2023) -
Naringenin and Its Derivatives—Health-Promoting Phytobiotic against Resistant Bacteria and Fungi in Humans
por: Duda-Madej, Anna, et al.
Publicado: (2022) -
The Impact of COVID-19 on the Mental Well-Being of College Students
por: Sauer, Natalia, et al.
Publicado: (2022) -
LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors
por: Sauer, Natalia, et al.
Publicado: (2022) -
Lipid Complications after Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
por: Bis, Gabriela, et al.
Publicado: (2020)